2011-12-13 |
2011-12-12 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
7,908,727
+100.0%
4.25
33,612,090
USD
|
7,908,727
+100.0%
|
4.25
|
33,612,090
USD
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
45,070,030
+104.1%
4.76
214,533,343
USD
|
45,070,030
+104.1%
|
4.76
|
214,533,343
USD
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,729,130
+4.2%
4.25
7,348,803
USD
|
1,729,130
+4.2%
|
4.25
|
7,348,803
USD
|
|
2011-12-09 |
2011-12-08 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,180,983
+2.9%
4.25
5,019,178
USD
|
1,180,983
+2.9%
|
4.25
|
5,019,178
USD
|
|
2011-12-09 |
2011-12-07 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
4,306,129
+11.9%
4.25
18,301,048
USD
|
4,306,129
+11.9%
|
4.25
|
18,301,048
USD
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
18,425
+1.7%
4.66
85,861
USD
|
18,425
+1.7%
|
4.66
|
85,861
USD
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
61,650
+6.0%
4.65
286,673
USD
|
61,650
+6.0%
|
4.65
|
286,673
USD
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
35,000
+11.4%
4.62
161,700
USD
|
35,000
+11.4%
|
4.62
|
161,700
USD
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
100,000
+48.1%
4.67
467,000
USD
|
100,000
+48.1%
|
4.67
|
467,000
USD
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
72,896
+53.9%
4.73
344,798
USD
|
72,896
+53.9%
|
4.73
|
344,798
USD
|
|
2011-11-30 |
2011-11-22 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
2,643
+2.0%
4.58
12,105
USD
|
2,643
+2.0%
|
4.58
|
12,105
USD
|
|
2011-11-30 |
2011-11-21 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
24,461
+22.6%
4.59
112,276
USD
|
24,461
+22.6%
|
4.59
|
112,276
USD
|
|
2011-06-27 |
2011-06-27 |
B
Purchase
|
Webster Stephen W
SVP, Finance & CFO
Officer
|
10,000
+7.8%
1.88
18,800
USD
|
10,000
+7.8%
|
1.88
|
18,800
USD
|
|
2011-06-22 |
2011-06-15 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
3,010
+1.6%
1.80
5,418
USD
|
3,010
+1.6%
|
1.80
|
5,418
USD
|
|
2011-06-22 |
2011-06-14 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
13,190
+7.6%
1.90
25,061
USD
|
13,190
+7.6%
|
1.90
|
25,061
USD
|
|
2010-12-23 |
2010-12-23 |
B
Purchase
|
DOUGHERTY MICHAEL R
President & CEO
Executive Director
|
30,000
+5.1%
1.18
35,400
USD
|
30,000
+5.1%
|
1.18
|
35,400
USD
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
376
-0.5%
1.18
445
USD
|
376
-0.5%
|
1.18
|
445
USD
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
14
-0.5%
1.18
17
USD
|
14
-0.5%
|
1.18
|
17
USD
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
884
-0.5%
1.18
1,046
USD
|
884
-0.5%
|
1.18
|
1,046
USD
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
60
-0.5%
1.18
71
USD
|
60
-0.5%
|
1.18
|
71
USD
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
31,666
-0.5%
1.18
37,461
USD
|
31,666
-0.5%
|
1.18
|
37,461
USD
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
885
-1.1%
1.19
1,052
USD
|
885
-1.1%
|
1.19
|
1,052
USD
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
33
-1.1%
1.19
39
USD
|
33
-1.1%
|
1.19
|
39
USD
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
2,086
-1.1%
1.19
2,479
USD
|
2,086
-1.1%
|
1.19
|
2,479
USD
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
142
-1.1%
1.19
169
USD
|
142
-1.1%
|
1.19
|
169
USD
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
74,670
-1.1%
1.19
88,738
USD
|
74,670
-1.1%
|
1.19
|
88,738
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
569
-0.7%
1.30
740
USD
|
569
-0.7%
|
1.30
|
740
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
21
-0.7%
1.30
27
USD
|
21
-0.7%
|
1.30
|
27
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
1,341
-0.7%
1.30
1,743
USD
|
1,341
-0.7%
|
1.30
|
1,743
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
91
-0.7%
1.30
118
USD
|
91
-0.7%
|
1.30
|
118
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
47,978
-0.7%
1.30
62,371
USD
|
47,978
-0.7%
|
1.30
|
62,371
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
233
-0.3%
1.28
298
USD
|
233
-0.3%
|
1.28
|
298
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
9
-0.3%
1.28
11
USD
|
9
-0.3%
|
1.28
|
11
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
550
-0.3%
1.28
702
USD
|
550
-0.3%
|
1.28
|
702
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
37
-0.3%
1.28
47
USD
|
37
-0.3%
|
1.28
|
47
USD
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
19,671
-0.3%
1.28
25,120
USD
|
19,671
-0.3%
|
1.28
|
25,120
USD
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
2,238
+0.0%
1.58
3,536
USD
|
2,238
+0.0%
|
1.58
|
3,536
USD
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
405,401
+6.3%
1.64
664,736
USD
|
405,401
+6.3%
|
1.64
|
664,736
USD
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
62
+0.0%
1.58
98
USD
|
62
+0.0%
|
1.58
|
98
USD
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
11,190
+6.2%
1.64
18,348
USD
|
11,190
+6.2%
|
1.64
|
18,348
USD
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
21,604
+0.3%
1.56
33,750
USD
|
21,604
+0.3%
|
1.56
|
33,750
USD
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
596
+0.3%
1.56
931
USD
|
596
+0.3%
|
1.56
|
931
USD
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
517,045
+8.8%
1.60
828,409
USD
|
517,045
+8.8%
|
1.60
|
828,409
USD
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
14,272
+8.6%
1.60
22,867
USD
|
14,272
+8.6%
|
1.60
|
22,867
USD
|
|
2010-05-27 |
2010-05-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
44,862
+0.8%
1.60
71,640
USD
|
44,862
+0.8%
|
1.60
|
71,640
USD
|
|
2010-05-27 |
2010-05-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,238
+0.8%
1.60
1,977
USD
|
1,238
+0.8%
|
1.60
|
1,977
USD
|
|
2010-05-27 |
2010-05-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
64,420
+1.1%
1.59
102,196
USD
|
64,420
+1.1%
|
1.59
|
102,196
USD
|
|
2010-05-27 |
2010-05-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,778
+1.1%
1.59
2,821
USD
|
1,778
+1.1%
|
1.59
|
2,821
USD
|
|
2010-05-27 |
2010-05-25 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
68,534
+1.2%
1.60
109,558
USD
|
68,534
+1.2%
|
1.60
|
109,558
USD
|
|
2010-05-27 |
2010-05-25 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,892
+1.2%
1.60
3,025
USD
|
1,892
+1.2%
|
1.60
|
3,025
USD
|
|
2010-05-03 |
2010-04-30 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
970
+0.6%
1.99
1,928
USD
|
970
+0.6%
|
1.99
|
1,928
USD
|
|
2010-05-03 |
2010-04-30 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
35,130
+0.6%
1.99
69,824
USD
|
35,130
+0.6%
|
1.99
|
69,824
USD
|
|
2010-05-03 |
2010-04-29 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
124
+0.1%
1.94
240
USD
|
124
+0.1%
|
1.94
|
240
USD
|
|
2010-05-03 |
2010-04-29 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
4,508
+0.1%
1.94
8,740
USD
|
4,508
+0.1%
|
1.94
|
8,740
USD
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
3,094
+2.0%
1.92
5,938
USD
|
3,094
+2.0%
|
1.92
|
5,938
USD
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
962
+0.6%
1.82
1,753
USD
|
962
+0.6%
|
1.82
|
1,753
USD
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
112,106
+2.0%
1.92
215,165
USD
|
112,106
+2.0%
|
1.92
|
215,165
USD
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
34,838
+0.6%
1.82
63,482
USD
|
34,838
+0.6%
|
1.82
|
63,482
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
98
+0.1%
2.06
202
USD
|
98
+0.1%
|
2.06
|
202
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
217
+0.1%
2.08
451
USD
|
217
+0.1%
|
2.08
|
451
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
609
+0.4%
2.08
1,267
USD
|
609
+0.4%
|
2.08
|
1,267
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
489
+0.3%
2.08
1,016
USD
|
489
+0.3%
|
2.08
|
1,016
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
3,550
+0.1%
2.06
7,313
USD
|
3,550
+0.1%
|
2.06
|
7,313
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
7,858
+0.1%
2.08
16,342
USD
|
7,858
+0.1%
|
2.08
|
16,342
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
22,055
+0.4%
2.08
45,894
USD
|
22,055
+0.4%
|
2.08
|
45,894
USD
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
17,709
+0.3%
2.08
36,790
USD
|
17,709
+0.3%
|
2.08
|
36,790
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,222
+0.8%
2.05
2,509
USD
|
1,222
+0.8%
|
2.05
|
2,509
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
11
+0.0%
2.06
23
USD
|
11
+0.0%
|
2.06
|
23
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,393
+0.9%
2.07
2,885
USD
|
1,393
+0.9%
|
2.07
|
2,885
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
44,258
+0.8%
2.05
90,862
USD
|
44,258
+0.8%
|
2.05
|
90,862
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
389
+0.0%
2.06
801
USD
|
389
+0.0%
|
2.06
|
801
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
50,451
+0.9%
2.07
104,489
USD
|
50,451
+0.9%
|
2.07
|
104,489
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
159
+0.1%
2.06
328
USD
|
159
+0.1%
|
2.06
|
328
USD
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
5,755
+0.1%
2.06
11,855
USD
|
5,755
+0.1%
|
2.06
|
11,855
USD
|
|
2009-09-24 |
2009-09-22 |
S
Sale
|
BVF PARTNERS L P/IL
Direct Beneficial Owner
Large shareholder
|
166,000
-3.9%
1.69
280,972
USD
|
166,000
-3.9%
|
1.69
|
280,972
USD
|
|